All posts tagged
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
What are the Best Countries to Recruit Biotech Talents in 2017?
Galapagos finds a Partner to Boost its Pipeline with Drug Combinations
Infographic: The Biggest Biotech Company in Each European Country
Galapagos kicks off a Phase IIa trial for Cystic Fibrosis
Galapagos gets another Milestone Payment from Gilead
One Step Closer to the First Triple Combination Therapy for Cystic Fibrosis
UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug
Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis
Which European Biotechs made it to the Billion-Euro Club in 2016?
Galapagos and AbbVie expand their Cystic Fibrosis collaboration
Two of the Biggest European Biotechs launch Antibody Program together
Labiotech UG, All Rights Reserved -
Send this to friend